A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure
- 1 March 1990
- journal article
- clinical trial
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 4 (2), 419-425
- https://doi.org/10.1007/bf01857748
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Long-term indoramin therapy in congestive heart failure: A double-blind, randomized, parallel placebo-controlled trialJournal of the American College of Cardiology, 1987
- Physician practice in the management of congestive heart failureJournal of the American College of Cardiology, 1986
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Hemodynamic and Electrophysiological Effects of a Novel Positive Inotropic Drug, OPC-8212, in Normal and “Failing” Guinea Pig Heart PreparationsJournal of Cardiovascular Pharmacology, 1986
- Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failureHeart and Vessels, 1986
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Acute Hemodynamic Effects of a New Positive Inotropic Agent, 3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), in Conscious and Anesthetized DogsJournal of Cardiovascular Pharmacology, 1986
- Studies on positive inotropic agents. I. Synthesis of 3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1H)-quinolinone and related compounds.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.Circulation, 1981